What’s being targeted in the 1 October PBS price cuts?
More than 2,000 medicine brands will be reduced in price for non-concessional patients in the 1 October wave of PBS price reductions.
Some leading brands will see their price reduced by as much as $20 per script, according to information released today by the Department of Health.
Among highly prescribed medicines, Irbesartan with hydrochlorothiazide is set to be reduced by 20%, while the price of rosuvastatin will decrease by more than 14%. Both telmisartan and atorvastatin will see their price drop by more than 12%.
Irbesartan, venlafaxine and duloxetine are all set to also drop in price by more than 10% from the 1 October. Click here for the list of cuts affecting the 20 most prescribed medicines.
Below is a list of the 10 biggest savings for non-concessional patients from 1 October 2016.
The savings for these medicines may vary depending on a number of factors such as formulation and strength, brand, the concessional status of the patient and any discretionary fees added or discounting by the pharmacist.
$ savings per script
% savings per script
|Alendronic acid with colecalciferol||Up to $23.37||Up to 61.02%|
|Alendronic acid with colecalciferol and calcium||Up to $23.37||Up to 61.02%|
|Cefalotin||Up to $13.27||Up to 34.65%|
|Methotrexate||Up to $10.91||Up to 28.49%|
|Fosinopril with hydrochlorothiazide||Up to $10.63||Up to 35.92%|
|Enalapril with hydrochlorothiazide||Up to $10.06||Up to 37.66%|
|Flucloxacillin||Up to $8.29||Up to 30.58%|
|Temozolomide||Up to $6.93||Up to 22.54%|
|Pioglitazone||Up to $6.72||Up to 18.52%|
|Donepezil||Up to $6.60||Up to 22.40%|
Click here for more information on the 1 October price cuts